HOME >> MEDICINE >> NEWS
NIAID initiates trial of experimental avian flu vaccine

Fast-track recruitment has begun for a trial to investigate the safety of a vaccine against H5N1 avian influenza, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced today.

Sites in Rochester, NY, Baltimore and Los Angeles will enroll a total of 450 healthy adults. The clinical sites are part of the NIAID-sponsored Vaccine and Treatment Evaluation Units (VTEU).

"While there have been relatively few cases worldwide of H5N1 avian influenza infection in humans, the public health community is concerned that the virus will develop the capability of efficiently spreading from human to human and thus create a risk for a worldwide pandemic," says NIAID Director Anthony S. Fauci, M.D.

"NIAID has supported research on H5N1, the strain responsible for this deadly form of avian influenza, since 1997 when the first cases in humans were reported. The initiation of this vaccine trial marks a key advance in our efforts to prepare to respond to an avian flu pandemic," adds Dr. Fauci.

Sanofi pasteur, Swiftwater, PA, manufactured the trial vaccine, which is an inactivated vaccine made from an H5N1 virus isolated in Southeast Asia in 2004. Sanofi pasteur, formerly Aventis Pasteur, was awarded a contract by NIAID to manufacture the H5N1 vaccine in May 2004.

This Phase I trial will test the vaccine's safety and ability to generate an immune response in 450 healthy adults aged 18 to 64. If the vaccine is shown to be safe in adults, there are plans to test it in other populations, such as the elderly and children.

H5N1 avian influenza leads to severe disease in both birds and humans. Between January 2004 and March 11, 2005, there were 69 confirmed cases of and 46 deaths from H5N1 infection in humans reported to the World Health Organization. To date, there has been a small number of cases where human-to-human transmission of the virus may have occurred. However, public
'"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
23-Mar-2005


Page: 1 2

Related medicine news :

1. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
2. NIAID begins enrolling volunteers for novel HIV vaccine study
3. NIAID-sponsored clinical trial aims to boost flu vaccine supply
4. NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks
5. NIAID launches influenza genome sequencing project
6. NIAID launches program to improve medical tools against emerging infectious diseases
7. NIAID forms network to tackle potentially fatal reaction to smallpox vaccine
8. NIAID rotavirus vaccine licensed for commercialization
9. Second NIAID SARS vaccine candidate helps mice fend off SARS
10. NIAID vaccine protects against SARS virus infection in mice
11. NIAID Ebola vaccine enters human trial

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2019)... LANCASTER, Pa. (PRWEB) , ... November 08, 2019 ... ... institution for the health care field, is pleased to announce that after the ... stay above the 90th percentile with a 94.73% average pass rate. The College’s ...
(Date:11/7/2019)... HAUPPAUGE, N.Y. (PRWEB) , ... November 06, 2019 , ... ... in fighting the flu is to get the flu shot. Since the flu season ... Flu Vaccination Clinic in early Fall, where their employees can simply sign-up and get ...
(Date:11/7/2019)... (PRWEB) , ... November 07, 2019 , ... , ... select southern markets. The product line includes a 4 and a 7 hour formulations. ... transmit diseases, such as Zika, West Nile Virus and Encephalitis, without exposing them to ...
(Date:11/7/2019)... , ... November 07, 2019 , ... ... co-founder of Ignite and Expand got together on the Shamangelic Healing Podcast ... of downloads skyrocketed. With a trending focus on learning ways to use bio-hacking ...
(Date:11/6/2019)... , ... November 06, 2019 , ... ... and the University of Kentucky Research Foundation (UKRF) today announced they have entered ... will give hemp-derived product companies access to the broad resources of each organization ...
Breaking Medicine News(10 mins):
(Date:11/5/2019)... MONTCLAIR, N.J. (PRWEB) , ... November 05, 2019 ... ... San Antonio, 555 South Alamo Street in Texas will be a timely program ... instruction in the management of chronic pain. , The Texas Medical Board requires ...
(Date:11/5/2019)... ... November 05, 2019 , ... ... Nov. 13-14: How to Build a Sponsor Risk Management Program, Friday, Nov. ... Wednesday-Friday, Nov. 13-15, 2019 • Philadelphia, PA , https://www.fdanews.com/cwiche6gcp , ...
(Date:11/4/2019)... ... ... E-Z-C Pak Creator Dr. Sarath Malepati reeled in famed entrepreneur ... Shark Tank on ABC. EZC Pak is a physician formulated immune support pack composed ... use in colds and flu. , Dr. Malepati negotiated a $125,000 investment for a ...
Breaking Medicine Technology:
Cached News: